Researchers have tested a novel therapeutic concept to treat virus-induced lung failure in patients with severe COVID-19 in a phase 2 clinical trial. The approach may also be applicable to other ...
Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Welcome to Tarsus’ Third Quarter 2024 Financial Results ...
Celiac Quebec (Cœliaque Québec) is co-organizing a first citizens' forum that will bring together patients, various ...
Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patien ...
Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Good afternoon, and welcome to Fractyl Health’s Third Quarter Financial Results and Business Updates Call. As a reminder, this conference ...
Ipsen presents 3 late-breaking presentations and 8 abstracts across rare cholestatic liver disease portfolio at AASLD 2024Iqirvo approved for use in the U.S. in June 2024, in the E.U. in September ...
It's been a week since Donald Trump's landslide re-election and some Democrats are using words like "realignment," ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback